bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2552
-0.0248 (-8.86%)
At close: Aug 14, 2025, 4:00 PM
0.2600
+0.0048 (1.88%)
After-hours: Aug 14, 2025, 7:57 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $7.15 million as of August 14, 2025. Its market cap has decreased by -74.33% in one year.
Market Cap
7.15M
Enterprise Value
8.04M
1-Year Change
-74.33%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $7.15M, a decrease of -84.11%. That is a compound annual growth rate of -46.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 7.15M | -49.56% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |